Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01455740 · ClinicalTrials.gov registry record · NA
A Commitment Device for Medication Adherence Among HIV Patients
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01455740 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 110 participants.
The verdict
NCT01455740, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
We used a randomized trial design combined with a comparison to a non-randomized control group to study patients on appropriate antiretroviral therapy (ART) having virologic failure within a publicly-funded HIV clinic serving Atlanta, GA.
Interventions
- BEHAVIORAL Provider Visit Incentive (PVI)
- BEHAVIORAL Incentive Choice (IC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01455740
The ClinicalTrials.gov registry entry for NCT01455740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Bureau of Economic Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Provider Visit Incentive (PVI) is the first listed.
NCT01455740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01455740 about?
NCT01455740 is a clinical study titled "A Commitment Device for Medication Adherence Among HIV Patients". We used a randomized trial design combined with a comparison to a non-randomized control group to study patients on appropriate antiretroviral therapy (ART) having virologic failure within a publicly-funded HIV clinic serving Atlanta, GA.
What is the current status of trial NCT01455740?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2011-10. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01455740?
The interventions under investigation include: Provider Visit Incentive (PVI) (BEHAVIORAL), Incentive Choice (IC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01455740?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.